Article: COVID-19 outbreak as a probable cause of increased risk of intracranial rebleeding in partially treated cerebral arteriovenous malformations

Patients who are infected with COVID-19 and have cerebral arteriovenous malformations which are partially treated or untreated may be more liable to rupture or bleed than not infected patients.

Citing Articles

Intracranial Hemorrhage Due to Potential Rupture of an Arteriovenous Malformation after BNT162b2 COVID-19 mRNA Vaccination in a Young Korean Woman: Case Report.

Kim B, Yoo M Vaccines (Basel). 2022; 10(3).

PMID: 35334996 PMC: 8953327. DOI: 10.3390/vaccines10030362.

COVID-19 outbreak as a probable cause of increased risk of intracranial rebleeding in partially treated cerebral arteriovenous malformations.

Ghorbani M, Lafta G, Rahbarian F Clin Case Rep. 2021; 9(10):e04893.

PMID: 34631077 PMC: 8489393. DOI: 10.1002/ccr3.4893.

References

1.

Ghorbani M, Lafta G, Rahbarian F . COVID-19 outbreak as a probable cause of increased risk of intracranial rebleeding in partially treated cerebral arteriovenous malformations. Clin Case Rep. 2021; 9(10):e04893. PMC: 8489393. DOI: 10.1002/ccr3.4893. View

2.

Saavedra J . Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities. Cell Mol Neurobiol. 2005; 25(3-4):485-512. PMC: 11529611. DOI: 10.1007/s10571-005-4011-5. View

3.

Klempin F, Mosienko V, Matthes S, Villela D, Todiras M, Penninger J . Depletion of angiotensin-converting enzyme 2 reduces brain serotonin and impairs the running-induced neurogenic response. Cell Mol Life Sci. 2018; 75(19):3625-3634. PMC: 7079801. DOI: 10.1007/s00018-018-2815-y. View

4.

Li M, Dong Y, Wang H, Guo W, Zhou H, Zhang Z . Cardiovascular disease potentially contributes to the progression and poor prognosis of COVID-19. Nutr Metab Cardiovasc Dis. 2020; 30(7):1061-1067. PMC: 7165120. DOI: 10.1016/j.numecd.2020.04.013. View

5.

Lai C, Shih T, Ko W, Tang H, Hsueh P . Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020; 55(3):105924. PMC: 7127800. DOI: 10.1016/j.ijantimicag.2020.105924. View

6.

Muhammad S, Petridis A, Cornelius J, Hanggi D . Letter to editor: Severe brain haemorrhage and concomitant COVID-19 Infection: A neurovascular complication of COVID-19. Brain Behav Immun. 2020; 87:150-151. PMC: 7199686. DOI: 10.1016/j.bbi.2020.05.015. View

7.

Subat Y, Dasenbrock H, Gross B, Patel N, Frerichs K, Du R . Periprocedural intracranial hemorrhage after embolization of cerebral arteriovenous malformations: a meta-analysis. J Neurosurg. 2019; 133(5):1417-1427. DOI: 10.3171/2019.5.JNS183204. View

8.

Wong S, Lui R, Sung J . Covid-19 and the digestive system. J Gastroenterol Hepatol. 2020; 35(5):744-748. DOI: 10.1111/jgh.15047. View

9.

Mouchtouris N, Jabbour P, Starke R, Hasan D, Zanaty M, Theofanis T . Biology of cerebral arteriovenous malformations with a focus on inflammation. J Cereb Blood Flow Metab. 2014; 35(2):167-75. PMC: 4426734. DOI: 10.1038/jcbfm.2014.179. View

10.

Muhammad S, Haasbach E, Kotchourko M, Strigli A, Krenz A, Ridder D . Influenza virus infection aggravates stroke outcome. Stroke. 2011; 42(3):783-91. DOI: 10.1161/STROKEAHA.110.596783. View

11.

Mosimann P, Chapot R . Contemporary endovascular techniques for the curative treatment of cerebral arteriovenous malformations and review of neurointerventional outcomes. J Neurosurg Sci. 2018; 62(4):505-513. DOI: 10.23736/S0390-5616.18.04421-1. View

COVID-19 Outbreak As a Probable Cause of Increased Risk of Intracranial Rebleeding in Partially Treated Cerebral Arteriovenous Malformations